How a new heart valve treatment can improve heart disease mortality rates
A new treatment available to combat valvular heart disease could be an opportunity to improve the care provided to those who would previously have been too ill for open heart surgery - and cut mortality rates in patients with the disease. Dr Mark De Belder explains.
Subscriber only content
You must be a paid subscriber to Health Service Journal magazine to read this article and receive complete, unrestricted access to hsj.co.uk
HSJ Subscribers:
If you are a Health Service Journal subscriber please sign in with your email address and click submit:
Not a HSJ subscriber?
Choose one of these options:
Subscribe today for immediate access to hsj.co.uk and Health Service Journal magazine
Find out more about the benefits of a subscription to HSJ by clicking below, or view a sample issue here
